Exozymes Inc.
EXOZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002010788
In the last 90 days, Exozymes Inc. insiders filed 1 open-market purchase and 0 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.05M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Exozymes Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 9 | 6 | −3 |
| Shares | 75.4K | 59.9K | −15.5K (−20.5%) |
| Value | $727.4K | $880.4K | +$152.9K (+21.0%) |
New holders (0)
Institutions that held Exozymes Inc. at the end of Q3 2025 but not at the end of Q2 2025.
None.
Sold out (3)
Institutions that held Exozymes Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 18,144 | $174.2K |
| Raymond James Financial Inc | 2,000 | $19.8K |
| Tower Research Capital LLC (TRC) | 344 | $3.40K |